


| Key | % Net Assets |
|---|---|
| 3.9% | |
| 3.8% | |
| 3.2% | |
| 3.0% | |
| 86.1% |
| Name | % Net Assets |
|---|---|
| BP | 3.9% |
| Royal Dutch Shell | 3.8% |
| HSBC Hldgs | 3.2% |
| GlaxoSmithKline | 3.0% |
| Treasury 4.25% 12/2055 | 2.6% |
| GlaxoSmithKline | 2.5% |
| DBR 4.25 07/39 | 2.4% |
| BG Group | 1.7% |
| BHP Billiton | 1.4% |
| AstraZeneca | 1.3% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 52.38p |
| Currency | GBP |
| Change | 0.13p |
| % | 0.25% |
| YTD change | 2.93p |
| YTD % | 5.93% |
| Fund Inception | 06/04/2005 |
|---|---|
| Fund Manager | Matthew Merritt |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £3000 |
| Additional | n/a |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.07 |
You are here: research